The global surge in electric vehicle adoption stands as a cornerstone of efforts to combat climate change and reduce reliance ...

To read the first article of the series, where JEC Composites Magazine spoke with the consortium to describe the motivations behind r-LightBioCom and the foundations of its multi-disciplinary approach ...

In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...

A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and Clinical Translation, published in the journal Antibiotics, examines how ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses ...

The Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial carried out in China, designed to evaluate the safety, tolerability, pharmacokinetics (PK), and ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...